YDES 株価推移チャート
YDES 収入
YD Bio Ltd
$5.29
1.87%
$0.09
終値： May 07, 16:00:00 GMT-4
$5.24
-0.87%
$-0.04
アフターマーケット：May 07, 20:00:00 GMT-4
戻る
YD Bio Ltd (YDES) 収入
主要データ
前終値
$5.19
始値
$5.19
当日レンジ
$5.11 - $5.3
52週レンジ
$4.73 - $25
取引高
1.1K
平均取引高
32.1K
配当利回り
--
1株当たり利益(TTM)
-1.32
時価総額
$369.8M
YDESとは何ですか？
YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. The company is headquartered in Taipei City, Taipei. The company went IPO on 2025-08-29. The firm is focused on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of diseases with unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. The company is focused on advancing a diversified portfolio of healthcare solutions across oncology diagnostics, regenerative medicine and clinical trial support. The company is a supplier of clinical trial drugs and has expanded into the development and distribution of post-market auxiliary products. Its core programs include Blood-Based Cancer Detection, Stem Cell- and Exosome-Based Ophthalmology Therapies, and Clinical Trial and AncillaryServices. The company is developing proprietary DNA methylation-based detection technology for a range of cancers, which includes a screening test for the early detection of pancreatic cancer and a monitoring test for recurrent breast cancer.
